Pineapple Express Cannabis (PNXP) Accumulated Expenses (2018 - 2025)

Pineapple Express Cannabis' (PNXP) quarterly Accumulated Expenses came in at $1.3 million in Q4 2025, up 8.51% quarter-over-quarter from $1.2 million in Q3 2025.

Pineapple Express Cannabis (PNXP) Accumulated Expenses (2018 - 2025) Analysis & Trends

Pineapple Express Cannabis has disclosed Accumulated Expenses across 5 years of filings, most recently posting $1.3 million for Q4 2025.

  • Accumulated Expenses for Q4 2025 came in at $1.3 million, changed N/A year-over-year; the trailing twelve-month figure through Oct 2025 was $1.3 million (changed N/A YoY), and the FY2021 annual result was $36135.0, up 113.82% from the prior year.
  • Accumulated Expenses came in at $1.3 million for Q4 2025 at Pineapple Express Cannabis, up from $1.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.3 million in Q4 2025 to a low of $36135.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn
10 Pineapple Express Cannabis - - -

Historic Data

Download Data
DateValue
Oct 31, 2025 1.26 Mn
Jul 31, 2025 1.16 Mn
Apr 30, 2025 1.06 Mn
Jan 31, 2021 36,135.00
Oct 31, 2020 36,135.00
Jul 31, 2020 33,085.00
Apr 30, 2020 30,730.00
Jan 31, 2020 16,900.00
Oct 31, 2019 16,900.00
Jul 31, 2019 14,700.00
Apr 30, 2019 12,650.00
Jan 31, 2019 8,650.00
Oct 31, 2018 8,650.00
Jan 31, 2018 7,650.00